Regenerative Pharmacology
Regenerative
pharmacology will have far higher development
requirements. In fact, the challenges associated with regenerative
pharmacology, i.e., curative therapeutics, will in many cases necessitate
complex mixtures of compounds [i.e., growth factors such as fibroblast
growth factor (FGF), epidermal growth factor (EGF), platelet-derived
growth factor, nerve growth factor (NGF), vascular endothelial
growth factor (VEGF), insulin-like growth factor
(IGF), bone morphogenic proteins (BMPs These chemicals have far greater
molecular weights (usually 10,000 to >100,000 mol. wt.) than those created
historically by the pharmaceutical industry..